Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+0.81%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Non Operating Interest Expenses (2017 - 2025)

Immuron (IMRN) posted Non Operating Interest Expenses of -$4678.4 for Q2 2025, down 9167.48% on a QoQ basis from -$50.48 in Q3 2024, and up 6.3% year-over-year from -$4401.2 in Q2 2024.

Analysis

Immuron (IMRN) Non Operating Interest Expenses (2017 - 2025) Analysis & Trends

Immuron has reported Non Operating Interest Expenses for 8 years, with the latest figure at -$4678.4 in Q2 2025.

  • On a quarterly basis, Non Operating Interest Expenses rose 6.3% year-over-year to -$4678.4 in Q2 2025; TTM through Jun 2025 was -$16005.0, a 135.9% decrease from a year earlier, with the FY2026 full-year figure at -$14712.0, down 20039.63% from the prior year.
  • Non Operating Interest Expenses was -$4678.4 for Q2 2025 at Immuron, down from -$50.48 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $4501.0 in Q4 2022, with the low at -$10596.7 in Q2 2021.
  • Average Non Operating Interest Expenses over 5 years is -$3158.6, with a median of -$4678.4 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses surged 47253.03% in 2022, then plunged 239.6% in 2023.
  • Over 5 years, Non Operating Interest Expenses stood at -$9.55 in 2021, then soared by 47253.03% to $4501.0 in 2022, then slumped by 239.6% to -$6283.4 in 2023, then jumped by 99.2% to -$50.48 in 2024, then plunged by 9167.48% to -$4678.4 in 2025.
  • The last three Non Operating Interest Expenses figures came in at -$4678.4 (Q2 2025), -$50.48 (Q3 2024), and -$4992.8 (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 221.78 Bn 207.79 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 189.46 Bn 186.20 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.47 Bn 122.62 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.64 Bn 74.65 Bn 3.93 Bn 11.00 Mn
5 Moderna 72.84 Bn 67.70 Bn 52.00 Mn -
6 Argenx Se 59.64 Bn 54.46 Bn 1.37 Bn -1.00 Mn
7 Alnylam Pharmaceuticals 33.65 Bn 30.35 Bn 992.69 Mn 82.05 Mn
8 Biogen 33.30 Bn 32.01 Bn 1.96 Bn -
9 Roivant Sciences 27.62 Bn 28.31 Bn 1.16 Mn -
10 Immuron 7.31 Mn -1.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -4,678.36
Sep 9, 2024 -50.48
Jun 30, 2024 -4,992.77
Dec 31, 2023 -6,283.36
Dec 31, 2022 4,501.00
Dec 31, 2021 -9.55
Jun 30, 2021 -10,596.73
Dec 31, 2020 -58.04
Jun 30, 2020 -14,177.40
Dec 31, 2019 -23.46
Dec 31, 2017 -2,896.97
API Access

Immuron Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IMRN&period=max&api_key=YOUR_API_KEY